Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun:127:104388.
doi: 10.1016/j.jcv.2020.104388. Epub 2020 Apr 28.

Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement

Andrew B Fleming  1 , Vanessa Raabe  2
Affiliations

Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement

Andrew B Fleming et al. J Clin Virol. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

References

    1. Shen C., Wang Z., Zhao F., Yang Y., Li J., Yuan J. Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma. JAMA. 2020 - PMC - PubMed
    1. Liu L., Wei Q., Lin Q., Fang J., Wang H., Kwok H. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4 - PMC - PubMed
    1. Jaume M., Yip M.S., Cheung C.Y., Leung H.L., Li P.H., Kien F. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcgammaR pathway. J. Virol. 2011;85:10582–10597. - PMC - PubMed
    1. Channappanavar R., Fehr A.R., Vijay R., Mack M., Zhao J., Meyerholz D.K. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016;19:181–193. - PMC - PubMed
    1. Ho M.-S.-S., Chen W.-J.-J., Chen W.-J.-Y., Lin S.-F.-F., Wang M.-C.-C., Di J. Neutralizing antibody response and SARS severity. Emerg. Infect. Dis. 2005;11:1730–1737. - PMC - PubMed